Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs

D Peric1, K Chvalova, G Rousselet

  • 1CEA, DSV, iRCM, Laboratoire de Génétique de la Radiosensibilité (LGR), Fontenay aux Roses, France.

Oncogene
|September 13, 2011
PubMed

Insights

Researchers identified cancer cells dependent on micro-RNA pathway by inhibiting Drosha and DGCR8. This allowed screening for growth-sustaining micro-RNAs, revealing functional differences and potential therapeutic targets in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • RNA Biology

Background:

  • Micro-RNAs (miRNAs) are deregulated in cancer, with some acting as tumor suppressors or oncogenes (oncomiRs).
  • Proteins in the RNA interference pathway are crucial, and their dysregulation can contribute to tumorigenesis.
  • Identifying oncomiRs is vital for cancer therapeutics, but miRNA redundancy complicates individual inhibition strategies.

Purpose of the Study:

  • To develop a method for identifying cancer cells dependent on the micro-RNA pathway.
  • To screen for specific micro-RNAs that sustain the growth of these identified cancer cells.
  • To investigate the functional roles of specific micro-RNAs and their targets in cancer cell proliferation.

Main Methods:

  • Utilized episomal vectors expressing small hairpin RNAs to target Drosha and DGCR8, key components of the micro-RNA processing complex.
  • Identified cancer cell lines exhibiting growth arrest upon microprocessor inhibition.
  • Performed complementation screens using individual micro-RNAs to rescue the observed growth arrest.

Main Results:

  • Identified specific cancer cell lines dependent on micro-RNA processing.
  • Discovered miR-19a, miR-19b, miR-20a, and miR-27b as key growth-sustaining micro-RNAs in these cells.
  • Demonstrated that phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a functional target involved in the growth arrest.

Conclusions:

  • The developed approach successfully identifies microprocessor-dependent cancer cells for functional micro-RNA screening.
  • The complementation screen revealed functional distinctions between homologous micro-RNAs.
  • Further phenotypic characterization of complemented cells will enable detailed functional studies of micro-RNAs in cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...